Pre-earnings options volume in Viking Therapeutics (VKTX) is 1.8x normal with calls leading puts 19:4. Implied volatility suggests the market is anticipating a move near 8.5%, or $2.24, after results are released. Median move over the past eight quarters is 7.8%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Viking Therapeutics price target lowered to $100 from $164 at Oppenheimer
- VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Buy Rating for Viking Therapeutics Driven by Promising VK2735 Oral GLP-1 Agonist Potential
- H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data
- Eli Lilly jumps as results from weight-loss pill study rival competitor’s